Von Willebrand disease (VWD) harms physical and mental health-related quality of life, with an increased burden for women and…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
IMMUNE THROMBOCYTOPENIA
NewsScientists say blood test can predict treatment effectiveness in ITP
The size of platelets, the cell fragments that help blood clot, and the levels of certain immune cells in the…
VON WILLEBRAND DISEASE
NewsNovel approach clears large, painful bleed in woman with VWD
Doctors successfully treated a large and painful muscle bleed in a 32-year-old woman with von Willebrand disease (VWD) using…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsSteroids, IVIG key in successful management of severe immune TTP
Adults with severe immune thrombotic thrombocytopenic purpura (TTP) who are at a high risk of bleeding may be managed…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsAnti-ADAMTS13 antibody levels could help guide TTP treatment
Levels of anti-ADAMTS13 antibodies measured after therapeutic plasma exchange (TPE) are associated with the time it takes to achieve normalization…
THROMBOTIC THROMBOCYTOPENIC PURPURA
NewsAn early diagnosis helps woman with TTP deliver healthy baby
A woman in Spain delivered a full-term, healthy baby after she was identified early as having congenital thrombotic thrombocytopenic…